SCHEMBL18977620

SCHEMBL18977620

O=S(=O)(c1ccccc1)N1CC(F)(F)C1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.55
PKM P14618 2/20 0.55
POLB P06746 2/20 0.52
ALDH1A1 P00352 5/20 0.50
CYP2D6 P10635 3/20 0.50
USP2 O75604 3/20 0.50
CYP1A2 P05177 3/20 0.50
CYP3A4 P08684 3/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
MAPK1 P28482 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
TSHR P16473 1/20 0.49
LMNA P02545 1/20 0.49
CYP2C19 P33261 1/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2557643 0.82 PKM (0.58) PKMPOLBALDH1A1MEN1KMT2A
SCHEMBL16372253 0.81 NAMPT (0.39) CYP2C9PKMPOLBALDH1A1USP2
SCHEMBL15765139 0.81 MMP2 (0.49) ALDH1A1USP2TSHRLMNA
SCHEMBL21510169 0.81 PKM (0.59) PKMPOLBALDH1A1MEN1KMT2A
SCHEMBL19746052 0.80 AKR1C3 (0.51) ALDH1A1MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7606500 0.80 POLB (0.56) CYP2C9PKMPOLBALDH1A1CYP2D6
SCHEMBL31426435 0.79 MBTD1 (0.52) ALDH1A1CYP3A4MEN1KMT2ASMN1; SMN2
SCHEMBL13188195 0.79 NAMPT (0.55) POLBALDH1A1MEN1KMT2ATSHR
SCHEMBL17841225 0.79 PKM (0.58) PKMPOLBALDH1A1SMN1; SMN2TSHR
SCHEMBL20791554 0.79 MAPT (0.67) ALDH1A1MEN1KMT2ASMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019493-B1 MODIFIED BET-PROTEIN INHIBITING DIHYDROCHINOXALINONES AND DIHYDROPYRIDOPYRAZINONES Bayer Pharma AG (DE) 2017-06-14 EP disclosed